山西医科大学学报
山西醫科大學學報
산서의과대학학보
JOURNAL OF SHANXI MEDICAL UNIVERSITY
2015年
3期
256-258
,共3页
马力群%王莉%段朝阳%马小琴%付荣国
馬力群%王莉%段朝暘%馬小琴%付榮國
마력군%왕리%단조양%마소금%부영국
多靶点治疗%肾病综合征%老年人
多靶點治療%腎病綜閤徵%老年人
다파점치료%신병종합정%노년인
multi-target therapy%nephrotic syndrome%aged
目的:探讨多靶点治疗老年肾病综合征的临床疗效。方法我院2012-05~2014-05收治的63例老年肾病综合征患者随机分为多靶点治疗组和对照组。多靶点治疗组应用强的松、吗替麦考酚酯、他克莫司联合治疗,对照组应用强的松和环磷酰胺治疗。治疗3个月后,观察各治疗组的临床表现和尿液以及血液生化指标。结果治疗3个月后,多靶点组患者的治疗总有效率为96.88%(31/32),明显高于对照组83.87%(26/31)(P<0.05);多靶点组患者的尿蛋白定量、血肌酐、胆固醇以及血清白蛋白均较对照组明显改善(P<0.05);多靶点组患者的复发率和不良反应发生率均明显低于对照组(P<0.05)。结论多靶点治疗老年肾病综合征的临床疗效显著。
目的:探討多靶點治療老年腎病綜閤徵的臨床療效。方法我院2012-05~2014-05收治的63例老年腎病綜閤徵患者隨機分為多靶點治療組和對照組。多靶點治療組應用彊的鬆、嗎替麥攷酚酯、他剋莫司聯閤治療,對照組應用彊的鬆和環燐酰胺治療。治療3箇月後,觀察各治療組的臨床錶現和尿液以及血液生化指標。結果治療3箇月後,多靶點組患者的治療總有效率為96.88%(31/32),明顯高于對照組83.87%(26/31)(P<0.05);多靶點組患者的尿蛋白定量、血肌酐、膽固醇以及血清白蛋白均較對照組明顯改善(P<0.05);多靶點組患者的複髮率和不良反應髮生率均明顯低于對照組(P<0.05)。結論多靶點治療老年腎病綜閤徵的臨床療效顯著。
목적:탐토다파점치료노년신병종합정적림상료효。방법아원2012-05~2014-05수치적63례노년신병종합정환자수궤분위다파점치료조화대조조。다파점치료조응용강적송、마체맥고분지、타극막사연합치료,대조조응용강적송화배린선알치료。치료3개월후,관찰각치료조적림상표현화뇨액이급혈액생화지표。결과치료3개월후,다파점조환자적치료총유효솔위96.88%(31/32),명현고우대조조83.87%(26/31)(P<0.05);다파점조환자적뇨단백정량、혈기항、담고순이급혈청백단백균교대조조명현개선(P<0.05);다파점조환자적복발솔화불량반응발생솔균명현저우대조조(P<0.05)。결론다파점치료노년신병종합정적림상료효현저。
Objective To investigate the clinical efficacy of multi-targets therapy in treatment of elderly nephrotic syndrome. Methods Sixty-three elderly nephrotic syndrome patients in our hospital from May 2012 to May 2014 were randomly divided into the multi-target group and control group. Patients in multi-target group were treated with prednisone, mycophenolate mofetil( MMF) , tacrolimus, while patients in control group were treated with prednisone and cyclophosphamide. Clinical efficacy, urine and blood biochemical indexes were estimated after 3-month treatment. Results After 3-month treatment, the total effective rate in multi-target group was 96. 88%(31/32), significantly higher than in control group(83. 87%,P<0. 05). The urinary protein,serum creatinine,cholesterol and serum albumin were significantly improved in multi-target group compared with control group(P<0. 05). The recurrence rates and incidences of side effects were significantly lower in multi-target group than in control group(P<0. 05). Conclusion The clinical efficacy of multi-targets therapy in treatment of elderly nephrotic syndrome is significant.